Better fertility research 

We’re on a mission to uncover the "why" behind infertility and work toward a future where every person with ovaries can predict their chances of getting pregnant.

Here's why we're modernizing fertility research

Today, research is reactive

Most of the data we have around fertility comes from patients in infertility clinics. That means we have little insight into fertility health earlier in life.

There’s a gender gap

Here’s a crazy stat: in 2019 alone, there were 1,003 studies about erectile dysfunction (!) compared to 178 studies dedicated to female infertility.

And… there isn’t enough of a focus on fertility

We’re seeing more funding in women’s health and wellness at large but fertility research is lagging far behind.

Modern Fertility research is proactive

Every Modern Fertility customer can opt-in to include their anonymized hormone levels in research. If you aren't a customer yet, you can contribute to closing the fertility research gap through surveys. We publish an annual Modern State of Fertility report, have numerous papers published in peer-reviewed science journals, and have presented our IRB-approved studies at The American Society for Reproductive Medicine (ASRM) Annual Conference.

Get involved

Want to get involved in research?


Opt-in to participate in research. This is 100% optional and 100% anonymous.



Update us on what happened since you tested. Closing the loop is essential for research.

Update us


If you haven’t tested your hormones with Modern Fertility you can test your hormones now or participate in a future Modern Fertility survey.

Our past research

  1. Modern State of Fertility 2022

    We teamed up with Bumble to find out how attitudes have changed around finding a partner and building families.

    See study

  2. Modern State of Fertility 2021

    We surveyed thousands to find out how the pandemic impacted people’s timelines for kids.

    See study

  3. Modern State of Fertility 2020

    We teamed up with SoFi to survey people with ovaries about how careers and money influence their plans for kids.

    See study

See also the results of our fertility survey 2019.

Anti-mullerian hormone levels among contraceptive users: evidence from a cross-sectional cohort of 27,125 individuals. (2021)

Should routine gynecologic care include screening to identify undetectable anti-Müllerian hormone levels? Analysis of results from over 18,000 reproductive-age women. (2021)

An examination of fertility knowledge before and after receiving at-home anti-Müllerian hormone test results. (2021)

The impact of at-home anti-Müllerian hormone test results on emotions and proactive fertility behaviors. (2021)

Hormonal contraceptive use is associated with significantly lower AMH levels in women of reproductive age. (2020)

The incidence of undetectable AMH levels in women seeking proactive fertility hormone testing. (2020)

Duration of contraceptive use is not associated with AMH levels. (2020)

A comprehensive examination of infertility stigma among fertile and infertile women in the United States. (2019)

Women’s knowledge about the impact of female and male age, weight, and smoking on fertility: results from a national survey. (2019)

Concordance of fingerstick and venipuncture sampling for fertility hormones. (2019)

Supporting women in the workforce: the importance of employer-provided supplemental fertility insurance benefits. (2019)

LGBTQ+ individuals' perceptions of reproductive hormone self-collection tests. (2019)

Healthcare providers as fertility information sources for cis heterosexual women and LGBTQ+ individuals. (2019)

Meet Dr. Nataki Douglas

“My excitement about Modern Fertility’s commitment to research is our ability to contribute to a greater understanding of normal reproductive physiology. This type of research gives women more insight into their bodies while also advancing the scientific community. Most research studies investigate disease — we’re fundamentally trying to better understand health.”

- Nataki Douglas, MD, PhD Chair of the Modern Fertility Medical Advisory Board OB-GYN, reproductive endocrinologist